4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-22-000816
Chief Scientific Officer acquired 42,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kidron Miriam Chief Scientific Officer | 2022-01-03 | Grant or award | +42,000 | 183,666 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kidron Miriam Chief Scientific Officer | 2022-01-03 | Grant or award · Stock Option (right to buy) | +72,000 | 72,000 | D: show line 2 in the form |
Loading xslF345X03/ownership.xml…